These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 2165946
1. Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy. Ng LL, Simmons D, Frighi V, Garrido MC, Bomford J, Hockaday TD. Diabetologia; 1990 Jun; 33(6):371-7. PubMed ID: 2165946 [Abstract] [Full Text] [Related]
2. Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria. Ng LL, Simmons D, Frighi V, Garrido MC, Bomford J. Diabetologia; 1990 May; 33(5):278-84. PubMed ID: 2165458 [Abstract] [Full Text] [Related]
3. Integrated analysis of erythrocyte Na+/H+ antiport activity and left ventricular myocardial function in type I insulin-dependent diabetes mellitus. Matteucci E, Di Bello V, Giampietro O. J Diabetes Complications; 1995 May; 9(4):208-11. PubMed ID: 8573728 [Abstract] [Full Text] [Related]
4. Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy. Düsing R, Sorger M, Mattes L, Göbel BO, Hoffmann G, Rosskopf D, Vetter H, Siffert W. Clin Investig; 1993 Feb; 71(2):119-25. PubMed ID: 8384910 [Abstract] [Full Text] [Related]
5. Erythrocyte sodium-hydrogen exchange and microalbuminuria in type I diabetes. Giampietro O, Matteucci E, Pedrinelli R. Diabetes Care; 1996 Sep; 19(9):995-7. PubMed ID: 8875095 [Abstract] [Full Text] [Related]
6. Erythrocyte Na+/H+ exchange and preclinical abnormalities of the left ventricular diastolic function in normotensive type 1 (insulin-dependent) diabetic patients. Giampietro O, Di Bello V, Matteucci E, Talarico L, Ruberti F, Boldrini E, Giorgi D, Giusti C. Acta Diabetol; 1997 Oct; 34(3):223-9. PubMed ID: 9401645 [Abstract] [Full Text] [Related]
7. Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics. Davies JE, Ng LL, Kofoed-Enevoldsen A, Li LK, Earle KA, Trevisan R, Viberti G. Kidney Int; 1992 Nov; 42(5):1184-90. PubMed ID: 1333551 [Abstract] [Full Text] [Related]
8. Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria. Parving HH. Diabetologia; 1991 Mar; 34(3):201. PubMed ID: 1653156 [No Abstract] [Full Text] [Related]
9. Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria. Trevisan R, Cipollina MR, Duner E, Trevisan M, Nosadini R. Diabetologia; 1996 Jun; 39(6):717-24. PubMed ID: 8781768 [Abstract] [Full Text] [Related]
10. Kinetics of the human leucocyte Na(+)-H+ antiport in essential hypertension. Ng LL, Fennell DA, Dudley C. J Hypertens; 1990 Jun; 8(6):533-7. PubMed ID: 2165087 [Abstract] [Full Text] [Related]
11. Leukocyte intracellular pH and Na/H antiporter activity in uraemia and type I diabetes mellitus. Poli de Figueiredo CE, Ng LL, Garrido MC, Davies JE, Ellory JC, Hendry BM. Nephrol Dial Transplant; 1991 Jun; 6(9):615-20. PubMed ID: 1660575 [Abstract] [Full Text] [Related]
12. Characteristics of the sodium/hydrogen exchange in non-insulin-dependent diabetic patients with microalbuminuria and hypertension. Zaidi KF, Yudkin JS. Clin Sci (Lond); 1996 Jan; 90(1):13-9. PubMed ID: 8697700 [Abstract] [Full Text] [Related]
14. Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy. Vervoort G, Elving LD, Wetzels JF, Lutterman JA, Smits P, de Pont JJ, Berden JH. Eur J Clin Invest; 2002 Feb; 32(2):93-9. PubMed ID: 11895455 [Abstract] [Full Text] [Related]
15. Stimulation of the human leucocyte Na+/H+ antiport by D-glucose is mediated by protein kinase C. Aston CW, Ng LL, Garrido MC, Bomford J. Diabetes Res; 1991 Oct; 18(2):49-52. PubMed ID: 1668730 [Abstract] [Full Text] [Related]
16. Leucocyte intracellular pH and Na+/H+ antiport activity in human hypertension. Ng LL, Dudley C, Bomford J, Hawley D. J Hypertens; 1989 Jun; 7(6):471-5. PubMed ID: 2550540 [Abstract] [Full Text] [Related]
17. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Trevisan R, Li LK, Messent J, Tariq T, Earle K, Walker JD, Viberti G. Diabetes; 1992 Oct; 41(10):1239-46. PubMed ID: 1327925 [Abstract] [Full Text] [Related]
18. Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy. Soussan K, Dausse E, Hannedouche T, Timsit J, Lemoult F, Boitard C, Grünfeld JP, Guicheney P. Am J Hypertens; 1993 Feb; 6(2):170-3. PubMed ID: 8385959 [Abstract] [Full Text] [Related]
19. Lipids and cellular Na+/H+ antiport activity in diabetic nephropathy. Ng LL, Davies JE. Kidney Int; 1992 Apr; 41(4):872-6. PubMed ID: 1325009 [Abstract] [Full Text] [Related]
20. Thiol group modulation of sodium-lithium countertransport kinetics in diabetic nephropathy. Jones SC, Thomas TH, Marshall SM. Diabetologia; 1997 Sep; 40(9):1079-84. PubMed ID: 9300245 [Abstract] [Full Text] [Related] Page: [Next] [New Search]